Use of a Taurolidine Containing Antimicrobial Wash to Reduce Prosthetic Device Infection After Trauma Surgery
Prosafeti
1 other identifier
observational
28
1 country
1
Brief Summary
A taurolidine-based antimicrobial solution, was evaluated for its safety and efficacy in preventing infections associated with prosthetic materials, such as joint replacements, plates, nails, and screws. This prospective observational study compared Taurolidine to infection rates from scientific literature.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
April 2, 2025
CompletedFirst Posted
Study publicly available on registry
April 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
January 20, 2026
January 1, 2026
8.6 years
April 2, 2025
January 15, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Infection
infection of osteosynthesis materials within 3 months after index procedure
3 months
Secondary Outcomes (1)
AE all grades, infections and all cause mortality during total follow up
36 months
Eligibility Criteria
trimalleolar farcture lower extremity, requiring osteosynthesis and external fixation undergoing revision to internal fixation; osteosynthesis of upper extremity undergoing revision to receive inverse shoulder prosthesis
You may qualify if:
- requires osteosynthesis with placement of prosthetic materials
You may not qualify if:
- minor, can't or won't sign PIC, can't undergo surgical procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Helios Cuxhaven
Cuxhaven, Germany
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- coordinating Principal investigator
Study Record Dates
First Submitted
April 2, 2025
First Posted
April 9, 2025
Study Start
January 1, 2022
Primary Completion (Estimated)
July 30, 2030
Study Completion (Estimated)
December 31, 2030
Last Updated
January 20, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share